Clinical trial
Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine…
NCT00262041 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00262041 |
|---|---|
| Title | Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents |
| Official title | A Phase 2, Randomized, Single-blind, Controlled, Multicenter Study to Compare the Safety and Immune Response of One Dose of Novartis Meningococcal ACWY Conjugate Vaccine With the Safety and Immune Response of One Dose of Licensed Meningococcal ACWY Polysaccharide Vaccine Administered to Healthy… |
| Lead sponsor | Novartis Vaccines, Industry |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prevention of Meningococcal Disease |
| Intervention type | Biological |
| Interventions | MenACWY-CRM conjugate vaccine, adjuvanted, unadjuvanted, MenACWY polysaccharide vaccine |
| Enrollment | 524 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Dec 6, 2005 |
| Last update posted | Jun 28, 2018 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: